Bayer to split off polymer division with IPO


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

BERLIN (AP) — German pharmaceuticals and chemicals company Bayer AG said Thursday it plans to spin off its polymer division with a separate stock listing.

The Leverkusen-based company that invented aspirin said the move would be part of an effort to focus the group on its health care and crop science businesses.

Bayer Material Sciences, or BMS, would have sales of 11.3 billion euros ($14.55 billion) based on 2013 figures, and have a global workforce of about 16,800 employees, said Chief Executive Marijn Dekkers. Analysts have valued BMS at about $10 billion, reported German news agency dpa.

The polymer division would likely keep its North American headquarters in Pittsburgh, Dekkers said.

He added that Bayer would use proceeds from the sale to invest in its life sciences business or reduce debt, or both.

Shares in the group were up 5.4 percent at 112.05 euros ($144.23) by mid-afternoon on the Frankfurt exchange Thursday.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

Business
The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast